Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« Novel nanobiologic trains immunity, curbs tumor growth in mice Next Article
Topical TYK2/JAK 1 inhibitor effective and tolerable in mild-to-moderate AD »
« Novel nanobiologic trains immunity, curbs tumor growth in mice Next Article
Topical TYK2/JAK 1 inhibitor effective and tolerable in mild-to-moderate AD »
Related Articles

February 4, 2022
Dapagliflozin improves stroke volume in patients with HFrEF

© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy